A detailed description of materials and methods is given in Methods. The work-flow and organization of the project are given in Supplementary Fig. 16 . Case series came from previously established collections with nationally representative recruitment: 2,000 samples were genotyped for each. The control samples came from two sources: half from the 1958 Birth Cohort and the remainder from a new UK Blood Service sample. The latter collection was established specifically for this study and is a UK national repository of anonymized DNA samples from 3,622 consenting blood donors. The vast majority of subjects were self-reported as of European Caucasian ancestry. All DNA samples were requantified and tested for degradation and PCR amplification. Genotyping was performed using GeneChip 500K arrays at the Affymetrix Services Lab (California): arrays not passing the 93% call rate threshold at P=0.33 with the Dynamic Model algorithm were repeated. CEL (cell intensity) files were transferred to WTCCC for quantile normalization, and genotypes called using a new genotyping algorithm, CHIAMO, developed for this project. QC/QA measures included sample call rate, overall heterozygosity and evidence of non-European ancestry (809 samples excluded; 16,179 retained for analysis). SNPs were excluded from analysis because of missing data rates, departures from Hardy-Weinberg equilibrium and other metrics (31,011 excluded; 469,557 retained). Standard 1-d.f. and 2-d.f. tests of case-control association were supplemented with bayesian approaches, multilocus methods (data imputation) and analyses with combined data sets, either as additional cases (to detect variants influencing multiple phenotypes) or as an expanded reference group (to increase power). Results for each SNP for all analyses reported will be available from http://www.wtccc.org.uk , as will details allowing other researchers to apply for access to WTCCC genotype data. Software packages developed within the WTCCC are available on request (see Methods for details).
>
Physiology
>
Organism Attribute
>
Heterozygote
Heterozygote
Heterozygote: A genetic state in which an individual possesses two different alleles of a given gene, one inherited from each parent.
This can result in the expression of a recessive trait or the codominant expression of both alleles.
Heterozygosity is an important concept in genetic research, as it can provide insights into inheritance patterns, disease risk, and population diversity.
Researchers in this field often utilize a variety of techniques, such as genetic sequencing and bioinformatic analyses, to identify and study heterozygous individuals and their implications for human health and evolution.
Effortlessly locate the best protocols from published literature, pre-prints, and patents, while leveraging AI-driven comparisons to identify the optimal products and procedures with PubCompare.ai's innovative solution.
This can result in the expression of a recessive trait or the codominant expression of both alleles.
Heterozygosity is an important concept in genetic research, as it can provide insights into inheritance patterns, disease risk, and population diversity.
Researchers in this field often utilize a variety of techniques, such as genetic sequencing and bioinformatic analyses, to identify and study heterozygous individuals and their implications for human health and evolution.
Effortlessly locate the best protocols from published literature, pre-prints, and patents, while leveraging AI-driven comparisons to identify the optimal products and procedures with PubCompare.ai's innovative solution.
Most cited protocols related to «Heterozygote»
Birth Cohort
BLOOD
Caucasoid Races
Cells
DNA, A-Form
Donor, Blood
Europeans
Gene Chips
Genotype
Heterozygote
Phenotype
DNA Chips
Europeans
Exome
Gene Deletion
Genome
Heterozygote
Hypersensitivity
INDEL Mutation
Insertion Mutation
Mutant Proteins
Nucleotides
Platinum
Transmission, Communicable Disease
TRIO protein, human
Once data is imported into R, the user can dynamically access and manipulate the population hierarchy with the function splitcombine() , subset the data set by population with popsub() , and check for cloned multilocus genotypes using mlg() . For data sets that include clones, the poppr function clonecorrect() will censor clones with respect to any level of a population hierarchy. In the case of missing data we use the commonly implemented, most parsimonious approach of treating missing states as novel alleles. This inherently makes analysis sensitive to missing data and genotyping error, but the user has tools available such as missingno() to filter out missing data at a per-individual or per-locus level. The user can also decide how uninformative loci (e.g., alleles occurring at minor frequencies; monomorphic loci; fixed heterozygous loci) are treated using the function informloci() . Thus, the user can specify a frequency for removal of uninformative loci. The user is encouraged to conduct analysis with and without missing data/uninformative loci to assess sensitivity to these issues when making inferences. A full list of functions available in poppr is provided in Table 1 .
Typical analyses in poppr start with summary statistics for diversity, rarefaction, evenness, MLG counts, and calculation of distance measures such as Bruvo’s distance, providing a suitable stepwise mutation model appropriate for microsatellite markers (Bruvo et al., 2004 (link)). Poppr will define MLGs in your data set, show where they cross populations, and can produce graphs and tables of MLGs by population that can be used for further analysis with the R package vegan (Oksanen et al., 2013 ). Many of the diversity indices calculated by the vegan functiondiversity() are useful in analyzing the diversity of partially clonal populations. For this reason, poppr features a quick summary table (Table 2 ) that incorporates these indices along with the index of association, IA (Brown, Feldman & Nevo, 1980 (link); Smith et al., 1993 (link)), and its standardized form, , which accounts for the number of loci sampled (Agapow & Burt, 2001 (link)). Both measures of association can detect signatures of multilocus linkage and values significantly departing from the null model of no linkage among markers are detected via permutation analysis utilizing one of four algorithms described in Table 3 (Agapow & Burt, 2001 (link)). The user can specify the number of samples taken from the observed data set to obtain the null distribution expected for a randomly mating population. Detailed examples of these analyses can be found in the poppr manual.
Typical analyses in poppr start with summary statistics for diversity, rarefaction, evenness, MLG counts, and calculation of distance measures such as Bruvo’s distance, providing a suitable stepwise mutation model appropriate for microsatellite markers (Bruvo et al., 2004 (link)). Poppr will define MLGs in your data set, show where they cross populations, and can produce graphs and tables of MLGs by population that can be used for further analysis with the R package vegan (Oksanen et al., 2013 ). Many of the diversity indices calculated by the vegan function
Full text: Click here
Alleles
Clone Cells
Heterozygote
Hypersensitivity
Mutation
Short Tandem Repeat
Vegan
Illumina short reads were obtained from Short Read Archive and capillary reads from TraceDB. Reads were aligned to the human reference genome with BWA26 . The consensus sequences were called by SAMtools27 and then divided into non-overlapping 100bp bins with a bin scored heterozygous if there is a heterozygote in the bin or being homozygous otherwise. The resultant bin sequences were taken as the input of the PSMC estimate. Coalescent simulation was done by ms28 and cosi21 . The simulated sequences were binned in the same way.
The free parameters in the discrete PSMC-HMM model are the scaled mutation rate, recombination rate and piecewise constant population sizes. The time interval each size parameter spans was manually chosen. The estimation-maximization iteration started from a constant-sized population history. The estimation step was done analytically; Powell’s direction set method is used for the maximization step. Parameter values stablized by the 20th iteration, and these were taken as the final estimate. All parameters are scaled to a constant that is further determined under the assumption of a neutral mutation rate 2.5×10−8.
The free parameters in the discrete PSMC-HMM model are the scaled mutation rate, recombination rate and piecewise constant population sizes. The time interval each size parameter spans was manually chosen. The estimation-maximization iteration started from a constant-sized population history. The estimation step was done analytically; Powell’s direction set method is used for the maximization step. Parameter values stablized by the 20th iteration, and these were taken as the final estimate. All parameters are scaled to a constant that is further determined under the assumption of a neutral mutation rate 2.5×10−8.
Capillaries
Consensus Sequence
Genome, Human
Heterozygote
Homozygote
MS 28
Recombination, Genetic
In the eigenanalysis of the Shriver data, we examine no more than two markers as independent regression variables for each marker we analyze, insisting that any marker that enters the regression be within 100,000 bases of the marker being analyzed. This slightly sharpens the results. Varying these parameters made little difference.
For all STRUCTURE runs, we ran with a burn-in of 10,000 iterations with 20,000 follow-on iterations, and no admixture model was used. Computations were carried out on a cluster of Intel Xeon compute nodes, each node having a 3.06-GHz clock.
For our coalescent simulations, we assumed a phylogenetic tree on the populations, and at each simulated marker, ran the coalescent back in time to the root of the tree. At this point we have a set of ancestors A of the sampled chromosomes. We now assume that the marker is biallelic and that the population frequency f of the variant allele in the ancestral population is distributed uniformly on the unit interval. Sample the frequency f and then choose an allele for each ancestor of A, picking the allele for each ancestor with probability f. Now retain the marker if it is polymorphic in our samples. This process is mathematically equivalent to having a very large outgroup population diverging from the sampled populations at the phylogenetic root, with the population panmictic before any population divergence, and ascertaining by finding heterozygotes in the outgroup. If our simulated samples have n individuals, our procedure yields a sample frequency that is approximately uniform on (1,2,…,2n − 1).
For the admixture analysis that created the plot ofFigure 8 we had a population C that was admixed with founder populations A and B. For each individual of C, we generated a mixing value x that is Beta-distributed B(3.5,1.5). Now for each marker independently, the individual was assigned to population A with probability x or B with probability 1 − x.
For all STRUCTURE runs, we ran with a burn-in of 10,000 iterations with 20,000 follow-on iterations, and no admixture model was used. Computations were carried out on a cluster of Intel Xeon compute nodes, each node having a 3.06-GHz clock.
For our coalescent simulations, we assumed a phylogenetic tree on the populations, and at each simulated marker, ran the coalescent back in time to the root of the tree. At this point we have a set of ancestors A of the sampled chromosomes. We now assume that the marker is biallelic and that the population frequency f of the variant allele in the ancestral population is distributed uniformly on the unit interval. Sample the frequency f and then choose an allele for each ancestor of A, picking the allele for each ancestor with probability f. Now retain the marker if it is polymorphic in our samples. This process is mathematically equivalent to having a very large outgroup population diverging from the sampled populations at the phylogenetic root, with the population panmictic before any population divergence, and ascertaining by finding heterozygotes in the outgroup. If our simulated samples have n individuals, our procedure yields a sample frequency that is approximately uniform on (1,2,…,2n − 1).
For the admixture analysis that created the plot of
Full text: Click here
Alleles
Chromosomes
Heterozygote
Neutrophil
Plant Roots
Trees
Most recents protocols related to «Heterozygote»
The presence and absence of pseudo-heterozygosity at a given site (coded as 1 and 0 respectively) was used as a phenotype to run GWAS. As a genotype, the matrix published by the 1001 Genomes Consortium containing 10 million SNPs was used [19 (link)]. To run all the GWAS, the pygwas package [https://github.com/timeu/PyGWAS; see [59 (link)]] with the amm (accelerated mixed model) option was used. The raw output containing all SNPs was filtered, removing all SNPs with a minor allele frequency below 0.05 and/or a -log10(p-value) below 4.
For each GWAS performed, the p-value as well as the position was used to call the peaks using the Fourier transform function in R (filterFFT), combined with the peak detection function (peakDetection), from the package NucleR 3.13, to automatically retrieve the position of each peak across the genome. From each peak, the highest SNPs within a region of +/− 10kb around the peak center were used (see the example in Additional file1 : Fig. S18). Using all 26647 SNPs, a summary table was generated with each pseudo-heterozygous SNP and each GWAS peak detected (Additional file 2 ). This matrix was then used to generate Fig. 2 C, applying thresholds of −log10(p-value) of 20 and a minor allele frequency of 0.1.
For each GWAS performed, the p-value as well as the position was used to call the peaks using the Fourier transform function in R (filterFFT), combined with the peak detection function (peakDetection), from the package NucleR 3.13, to automatically retrieve the position of each peak across the genome. From each peak, the highest SNPs within a region of +/− 10kb around the peak center were used (see the example in Additional file
Full text: Click here
Genome
Genome-Wide Association Study
Genotype
Heterozygote
Phenotype
From the raw VCF files SNP positions containing heterozygous labels were extracted using GATK VariantFiltration. From the 3.3 million of heterozygous SNPs extracted, two filtering steps were then applied. Only SNPs with a frequency of at least 5% of the population and located in TAIR10-annotated coding regions were kept. After those filtering steps a core set of 26,647 SNPs were retained for further analysis (see Additional file 1 : Fig. S17). Gene names and features containing those pseudo-SNPs were extracted from the TAIR10 annotation.
Full text: Click here
Genes
Heterozygote
Single Nucleotide Polymorphism
From the VCF, Plink was used to generate .ped and .map files. (http://pngu.mgh.harvard.edu/purcell/plink/ ) [58 (link)]. To detect and characterize the stretches of heterozygosity the package “detectRUNS” in R was then used. (https://github.com/bioinformatics-ptp/detectRUNS/tree/master/detectRUNS ). We used the function slidingRuns.run with the following parameters: WindowSize=10, threshold=0.05, RoHet=True, minDensity=1/100, rest as default.
Full text: Click here
Heterozygote
Trees
Drop-in and drop-out measurements for 12 samples.
Sample | Input(ng) | Mean coverage | Drop-in | Drop-out |
---|---|---|---|---|
1 | 20 | 657 | 0.0195 | 0 |
2 | 20 | 40 | 0.0227 | 0 |
3 | 20 | 20 | 0.0237 | 0.0040 |
4 | 20 | 8 | 0.0243 | 0.0537 |
5 | 20 | 4 | 0.0220 | 0.2597 |
6 | 20 | 2 | 0.0167 | 0.6160 |
7 | 20 | 1 | 0.0067 | 0.9223 |
8 | 1 | 105 | 0.0179 | 0 |
9 | 0.25 | 59 | 0.0143 | 0.0196 |
10 | 0.125 | 35 | 0.0129 | 0.0822 |
11 | 0.031 | 12 | 0.0092 | 0.5558 |
12 | 0.015 | 9 | 0.0091 | 0.7461 |
Drop-in is measured as the proportion of reads indicating an allele that is not present in the genotype the read reports for. Drop-out is measured as the proportion of heterozygous loci where there are reads for only one allele type
The simlation uses 3929 SNPs from Tillmar et al. [13 (link)], describing a SNP panel with autosomal SNPs evenly spread across the chromosomes. Genetic positions are downloaded from Ruther’s repository [22 (link)]. From Tillmar et al, we further use genotype data for the Coriell sample NA12878 to obtain coverage statistics. Allele frequencies are extracted for individuals with European ancestry (CEU) from the 1000 Genomes project [23 ]. We generate founder alleles through the population model in Sect.
Our five example pedigrees. For each we indicate the numbering of the persons, the numbering of the parent–child relationships and which persons are tested (filled symbols)
For each simulated case we also estimate Jacquard coefficients using NgsRelate [18 (link)]. We use VCF-files as input, with PL-fields derived from the same data likelihoods we use in our proposed method. The Euclidean distances from the estimated point of non-inbred coefficients to corresponding points representing the second cousin relationship or unrelatedness are computed. Comparing the difference in distances to a cutoff value yields a classification of cases into related or unrelated. Varying the cutoff value yields receiver operating characteristic (ROC) curves seen in Figs.
Full text: Click here
Alleles
Chromosomes
Europeans
Figs
Gamma Rays
Gene Order
Genome
Genotype
GZMB protein, human
Heterozygote
Pattern, Inheritance
Single Nucleotide Polymorphism
Vision
SNP genotypes were denoted as 0/0 for homozygous reference alleles, 0/1 for heterozygous alleles, and 1/1 for homozygous alternate alleles (0: reference allele; 1: alternate allele). Association analysis of logistic regression was performed using the Python package statsmodels (Seabold et al., 2010 ). An additive model was used for the association between the SNPs and AMD. For additive logistic regression analysis, homozygous reference alleles, heterozygous alleles, and homozygous alternate alleles were respectively defined as the values 0, 1, and 2. The clinical data mining and management of the SQL server in TCVGH was conducted using Microsoft Azure Data Studio. Patient comorbidities included hypertension (ICD-9-CM codes 401.xx—405.xx), coronary artery disease (410.xx—414.xx), cardiac dysrhythmias (427.xx, 785.0, and 785.1), cerebrovascular diseases (433.xx—438.xx), chronic respiratory diseases (490—496), and hyperlipidemia (272.x). Individuals with any comorbidity were identified through diagnoses performed during at least two ambulatory visits to TCVGH. Statistical significance was defined as a p-value < 0.05.
Survival analysis was assessed by the Kaplan–Meier estimate using the R package survival (Therneau and Grambsch, 2000 ). Observation time was defined as the period of duration from the first outpatient visit for a comorbidity to the first time receiving a diagnosis for AMD. The survival curve was plotted by the R package survminer (https://CRAN.R-project.org/package=survminer ). Log-rank tests for significant differences in survival time between the two groups were performed using the survdiff function in the survival package. A Cox proportional hazard (PH) model was used to estimate the hazard ratio (HR) using the coxph function in the survival package. For Cox PH model, homozygous reference alleles (0/0), heterozygous alleles (0/1), and homozygous alternate alleles (1/1) were respectively defined as the values 0, 1, and 2.
Survival analysis was assessed by the Kaplan–Meier estimate using the R package survival (Therneau and Grambsch, 2000 ). Observation time was defined as the period of duration from the first outpatient visit for a comorbidity to the first time receiving a diagnosis for AMD. The survival curve was plotted by the R package survminer (
Full text: Click here
Alleles
Azure A
Cardiac Arrhythmia
Cerebrovascular Disorders
Coronary Artery Disease
Diagnosis
Disease, Chronic
Genotype
Heterozygote
High Blood Pressures
Homozygote
Hyperlipidemia
Outpatients
Patients
Python
Respiration Disorders
Respiratory Rate
Single Nucleotide Polymorphism
Top products related to «Heterozygote»
Sourced in United States, Montenegro, Germany, United Kingdom, Japan, China, Canada, Australia, France, Colombia, Netherlands, Spain
C57BL/6J is a mouse strain commonly used in biomedical research. It is a common inbred mouse strain that has been extensively characterized.
Sourced in United States, Montenegro, Japan, Canada, United Kingdom, Germany, Macao, Switzerland, China
C57BL/6J mice are a widely used inbred mouse strain. They are a commonly used model organism in biomedical research.
Sourced in United States, Germany, Sao Tome and Principe, United Kingdom, Switzerland, Macao, China, Australia, Canada, Japan, Spain, Belgium, France, Italy, New Zealand, Denmark
Tamoxifen is a drug used in the treatment of certain types of cancer, primarily breast cancer. It is a selective estrogen receptor modulator (SERM) that can act as both an agonist and antagonist of the estrogen receptor. Tamoxifen is used to treat and prevent breast cancer in both men and women.
Sourced in United States, Montenegro, United Kingdom, Germany, Australia, China, Canada
C57BL/6 is a widely used inbred mouse strain. It is a robust, readily available laboratory mouse model.
Sourced in United States, China, Germany, United Kingdom, Hong Kong, Canada, Switzerland, Australia, France, Japan, Italy, Sweden, Denmark, Cameroon, Spain, India, Netherlands, Belgium, Norway, Singapore, Brazil
The HiSeq 2000 is a high-throughput DNA sequencing system designed by Illumina. It utilizes sequencing-by-synthesis technology to generate large volumes of sequence data. The HiSeq 2000 is capable of producing up to 600 gigabases of sequence data per run.
Sourced in United States, Montenegro, Canada, China, France, United Kingdom, Japan, Germany
C57BL/6 mice are a widely used inbred mouse strain commonly used in biomedical research. They are known for their black coat color and are a popular model organism due to their well-characterized genetic and physiological traits.
Sourced in United States, China, Germany, United Kingdom, Canada, Switzerland, Sweden, Japan, Australia, France, India, Hong Kong, Spain, Cameroon, Austria, Denmark, Italy, Singapore, Brazil, Finland, Norway, Netherlands, Belgium, Israel
The HiSeq 2500 is a high-throughput DNA sequencing system designed for a wide range of applications, including whole-genome sequencing, targeted sequencing, and transcriptome analysis. The system utilizes Illumina's proprietary sequencing-by-synthesis technology to generate high-quality sequencing data with speed and accuracy.
Sourced in China, United States, Germany, United Kingdom, Canada, Japan, France, Italy, Morocco, Spain, Netherlands, Montenegro, Belgium, Portugal, Ireland, Hungary
The C57BL/6 mouse is a widely used inbred mouse strain. It is a common laboratory mouse model utilized for a variety of research applications.
Sourced in China, Japan, Germany, France, United Kingdom, United States, Italy, Canada, Montenegro, Belgium, Morocco, Netherlands, Spain
The C57BL/6J mouse is a widely used laboratory mouse strain. It is an inbred strain that has a black coat color. The C57BL/6J mouse is commonly used as a control strain in various research applications.
Sourced in United States, United Kingdom, Denmark, Belgium, Spain, Canada, Austria
Stata 12.0 is a comprehensive statistical software package designed for data analysis, management, and visualization. It provides a wide range of statistical tools and techniques to assist researchers, analysts, and professionals in various fields. Stata 12.0 offers capabilities for tasks such as data manipulation, regression analysis, time-series analysis, and more. The software is available for multiple operating systems.
More about "Heterozygote"
Heterozygosity is a fundamental concept in genetics, referring to the presence of two different alleles of a gene within an individual.
This genetic state can result in the expression of a recessive trait or the codominant expression of both alleles.
Understanding heterozygosity is crucial in genetic research, as it provides insights into inheritance patterns, disease risk, and population diversity.
Researchers in this field often utilize a variety of techniques, such as genetic sequencing and bioinformatic analyses, to identify and study heterozygous individuals.
This includes the use of well-established mouse models, like the C57BL/6J strain, as well as advanced sequencing technologies, such as the HiSeq 2000 and HiSeq 2500.
Heterozygosity can have important implications for human health and evolution.
For example, the administration of tamoxifen, a drug commonly used in cancer treatment, can have varying effects on individuals depending on their genetic makeup, including their heterozygous status.
To enhance the reproducibility and efficiency of Heterozygote research, scientists can leverage AI-powered platforms like PubCompare.ai.
This innovative solution allows researchers to effortlessly locate the best protocols from published literature, pre-prints, and patents, while also leveraging AI-driven comparisons to identify the optimal products and procedures.
By incorporating insights from Heterozygote research and utilizing advanced tools like PubCompare.ai, researchers can take their work to new heights, unlocking a deeper understanding of inheritance, disease, and population genetics.
With the help of these resources, scientists can navigate the complex landscape of Heterozygote research with confidence and ease.
This genetic state can result in the expression of a recessive trait or the codominant expression of both alleles.
Understanding heterozygosity is crucial in genetic research, as it provides insights into inheritance patterns, disease risk, and population diversity.
Researchers in this field often utilize a variety of techniques, such as genetic sequencing and bioinformatic analyses, to identify and study heterozygous individuals.
This includes the use of well-established mouse models, like the C57BL/6J strain, as well as advanced sequencing technologies, such as the HiSeq 2000 and HiSeq 2500.
Heterozygosity can have important implications for human health and evolution.
For example, the administration of tamoxifen, a drug commonly used in cancer treatment, can have varying effects on individuals depending on their genetic makeup, including their heterozygous status.
To enhance the reproducibility and efficiency of Heterozygote research, scientists can leverage AI-powered platforms like PubCompare.ai.
This innovative solution allows researchers to effortlessly locate the best protocols from published literature, pre-prints, and patents, while also leveraging AI-driven comparisons to identify the optimal products and procedures.
By incorporating insights from Heterozygote research and utilizing advanced tools like PubCompare.ai, researchers can take their work to new heights, unlocking a deeper understanding of inheritance, disease, and population genetics.
With the help of these resources, scientists can navigate the complex landscape of Heterozygote research with confidence and ease.